Clinical research

Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)


Emanuele Meliga
Emanuele Meliga1,2, MD; Hector M Garcia-Garcia1, MD, MSc; Marco Valgimigli3, MD, PhD; Alaide Chieffo4, MD; Giuseppe Biondi-Zoccai5, MD; Andrew O Maree6, MD; Nieves Gonzalo1, MD; Stephane Cook7, MD; Ignacio Cruz-Gonzalez6, MD; Sebastiano Marra2, MD; Stefano De Servi8, MD; Igor F Palacios6, MD; Stephan Windecker7, MD; Ron van Domburg1, PhD; Antonio Colombo4, MD; Imad Sheiban5, MD; Patrick W Serruys1, MD, PhD, FACC, FESC.
1. Department of Interventional Cardiology, Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands; 2. Department of Interventional Cardiology, S. Giovanni Battista Hospital, Turin, Italy; 3. Department of Interventional Cardiology, S. Ann

Aims: Diabetes mellitus (DM) plays an important role in the development of coronary artery disease. Although previous studies have associated drug-eluting stent (DES) implantation in diabet

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

diabetes mellitusunprotected left main coronary artery diseasedrug eluting stents
Read next article
European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions.

Latest news